Valuation: Qinghai Biotech Pharmaceutical Group Limited

Market Cap 151M 19.29M 17.48M 16.16M 14.58M 27.49M 1.82B 28.45M 194M 77M 971M 72.37M 70.84M 3.08B P/E 2024
-2.61x
P/E 2025 -7.56x
Enterprise Value 55.16M 7.03M 6.37M 5.89M 5.32M 10.02M 663M 10.37M 70.8M 28.07M 354M 26.39M 25.83M 1.12B EV / Sales 2024
-0.1x
EV / Sales 2025 1.85x
Free-Float
43.07%
Yield 2024 *
-
Yield 2025 -
1 month-7.89%
3 months-33.94%
6 months-70.80%
Current year-58.29%
1 week 1.46
Extreme 1.46000000
1.46
1 month 0.33
Extreme 0.33
1.58
Current year 0.33
Extreme 0.33
10.95
1 year 0.33
Extreme 0.33
10.95
3 years 0.33
Extreme 0.33
10.95
5 years 0.33
Extreme 0.33
10.95
10 years 0.33
Extreme 0.33
25.5
Manager TitleAgeSince
Chief Executive Officer 45 26/02/2019
Comptroller/Controller/Auditor 50 01/04/2016
Director TitleAgeSince
Chairman 62 10/10/2022
Director/Board Member 61 11/01/2017
Chairman 45 02/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
7/22/20 A Other

Director

6,000,000 0.1190%
7/22/20 A Other

Chief Executive Officer

40,000,000 0.7933%
7/22/20 A Other

Director

6,000,000 0.1190%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-66.44%-35.11% 19.29M
+1.18%-1.28%-16.05%+13.29% 186B
+1.85%+1.04%+6.99%+42.70% 124B
-0.88%-4.98%-17.08%+9.86% 119B
+1.36%-5.91%-43.00%+3.16% 91.43B
+2.96%+7.64%-1.76%+80.54% 66.67B
+1.08%+2.90%+12.95%-7.56% 58.76B
+0.89%+4.17%+0.39%+62.87% 54.99B
-0.68%+6.83%-1.64%+55.26% 49.93B
-1.28%-0.43% - - 35.13B
Average +0.37%-1.74%-13.96%+25.00% 79B
Weighted average by Cap. +0.45%-3.32%-9.99%+27.13%

Financials

2024 2025
Net sales 185M 23.63M 21.41M 19.8M 17.87M 33.67M 2.23B 34.86M 238M 94.33M 1.19B 88.66M 86.78M 3.78B 139M 17.73M 16.07M 14.86M 13.41M 25.27M 1.67B 26.16M 179M 70.79M 893M 66.54M 65.13M 2.83B
Net income -46.36M -5.91M -5.35M -4.95M -4.47M -8.42M -557M -8.72M -59.49M -23.59M -298M -22.17M -21.7M -945M -46.68M -5.95M -5.39M -4.99M -4.5M -8.48M -561M -8.78M -59.91M -23.75M -300M -22.33M -21.85M -951M
Net Debt -139M -17.71M -16.05M -14.85M -13.39M -25.24M -1.67B -26.13M -178M -70.72M -892M -66.47M -65.06M -2.83B -96.14M -12.25M -11.1M -10.27M -9.27M -17.46M -1.16B -18.08M -123M -48.92M -617M -45.99M -45.01M -1.96B
Projected Income Statement - Annual - Qinghai Biotech Pharmaceutical Group Limited
Logo Qinghai Biotech Pharmaceutical Group Limited
Kaisa Health Group Holdings Ltd, formerly Mega Medical Technology Ltd, is an investment holding company principally engaged in the manufacturing and sale of dental prosthetics and implant instruments. The Company operates its business through two segments. The Dental Business segment is mainly engaged in the manufacturing of and trading in dental products. The Health Care Business segment mainly engages in the provision of services for sport rehabilitation, including postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services, as well as health leisure business.
Employees
1,340
Date Price Change Volume
13/11/26 HK$1.460 0.00% 0
12/11/26 HK$1.460 0.00% 0
11/11/26 HK$1.460 0.00% 0
10/11/26 HK$1.460 0.00% 0
09/11/26 HK$1.460 0.00% 0